Cytokinetics Inc (NASDAQ:CYTK) has a beta value of 0.68 and has seen 1.22 million shares traded in the last trading session. The company, currently valued
During the last session, Cytokinetics Inc (NASDAQ:CYTK)’s traded shares were 1.01 million, with the beta value of the company hitting 0.69. At the end of
In the last trading session, 1.61 million shares of the Cytokinetics Inc (NASDAQ:CYTK) were traded, and its beta was 0.68. Most recently the company’s share
In the last trading session, 4.05 million Cytokinetics Inc (NASDAQ:CYTK) shares changed hands as the company’s beta touched 0.68. With the company’s per share price
In last trading session, Cytokinetics Inc (NASDAQ:CYTK) saw 1.41 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price level
Cytokinetics Inc (NASDAQ:CYTK) has a beta value of 0.69 and has seen 2.51 million shares traded in the last trading session. The company, currently valued
During the last session, Cytokinetics Inc (NASDAQ:CYTK)’s traded shares were 21.5 million, with the beta value of the company hitting 0.69. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
